Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

"Concerns arise over GLP-1 use during major surgeries like joint replacements. A study reveals optimal timing for stopping Ozempic to reduce anesthesia risks." ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...